Literature DB >> 1849409

Eosinophil activation in systemic sclerosis.

R Gustafsson1, K Fredens, O Nettelbladt, R Hällgren.   

Abstract

Circulating levels of eosinophil cationic protein (ECP) were increased 4-fold in patients with systemic sclerosis (SSc) compared with those in healthy control subjects. There was no correlation between the ECP concentrations and laboratory indices of inflammatory activity or visceral involvement. Mean ECP levels were higher in patients with a history of occupational exposure to silica, even though patients who had no such history also had ECP levels higher than normal. The patients had increased bronchoalveolar levels of ECP, which correlated with impaired lung functioning. Skin infiltration with activated eosinophils and extracellular deposits of ECP were present in skin biopsy samples from the SSc patients. We conclude that eosinophil activation is part of the inflammatory process in SSc.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849409     DOI: 10.1002/art.1780340406

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

Review 1.  The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide.

Authors:  S J Oliver
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

2.  Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.

Authors:  B Gudbjörnsson; R Hällgren; O Nettelbladt; R Gustafsson; A Mattsson; E af Geijerstam; T H Tötterman
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

3.  Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.

Authors:  C Mavalia; C Scaletti; P Romagnani; A M Carossino; A Pignone; L Emmi; C Pupilli; G Pizzolo; E Maggi; S Romagnani
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

4.  Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.

Authors:  M R Hussein; H I Hassan; E R M Hofny; M Elkholy; N A Fatehy; A E A Abd Elmoniem; A M Ezz El-Din; O A Afifi; H G Rashed
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

5.  Increased levels of alternatively spliced interleukin 4 (IL-4delta2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis.

Authors:  L I Sakkas; C Tourtellotte; S Berney; A R Myers; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

6.  The effect of eosinophils on collagen gel contraction and implications for tissue remodelling.

Authors:  U Zagai; C M Sköld; A Trulson; P Venge; J Lundahl
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

7.  Associations between peripheral blood eosinophil counts in patients with systemic sclerosis and disease severity.

Authors:  Katsutoshi Ando; Tamao Nakashita; Norihiro Kaneko; Kazuhisa Takahashi; Shinji Motojima
Journal:  Springerplus       Date:  2016-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.